Updated analysis of vitamin D receptor gene FokI polymorphism and prostate cancer susceptibility
| Autor: | Jing Chen, Yang-Zhi Chen, Jian-Gang Zou, Li Zuo, Lifeng Zhang, Yuanyuan Mi |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty Population Subgroup analysis cancer risk Calcitriol receptor polymorphism 03 medical and health sciences Prostate cancer 0302 clinical medicine Clinical Research Internal medicine Genetic model medicine vitamin D receptor Allele education Gene education.field_of_study business.industry General Medicine medicine.disease 030104 developmental biology 030220 oncology & carcinogenesis Vitamin d receptor gene business |
| Zdroj: | Archives of Medical Science : AMS |
| ISSN: | 1734-1922 |
| DOI: | 10.5114/aoms.2016.61793 |
| Popis: | Introduction Polymorphisms of the vitamin D receptor (VDR) gene have been investigated in various case-control studies to evaluate prostate cancer susceptibility; however, published data on the association between vitamin D receptor gene FokI polymorphism and prostate cancer risk are inconclusive. Material and methods To assess the impact of vitamin D receptor gene FokI polymorphism, we performed a meta-analysis of eligible studies including 9,720 patients and 9,710 control subjects. Results The overall results indicated no obvious association of this variant on prostate cancer risk. However, in subgroup analysis by ethnicity, positive associations existed in Caucasian descendents for allelic contrast (OR = 1.03, 95% CI: 1.00–1.06, pheterogeneity = 0.552, p = 0.026) and the dominant genetic model (OR = 1.03, 95% CI: 1.00–1.05, pheterogeneity = 0.856, p = 0.032). In the subgroup analysis by tumor stage, there was a significant association between this variant and advanced prostate cancer under the recessive genetic model (OR = 1.15, 95% CI: 1.01–1.32, pheterogeneity = 0.469, p = 0.032). In the subgroup analysis by source of control, association of the VDR FokI polymorphism and prostate cancer susceptibility was also found in population-based studies under homozygote comparison and the recessive genetic model. Conclusions The VDR FokI polymorphism may contribute to the risk of developing prostate cancer in Caucasian and population-based studies. Further large, well-designed studies are warranted to confirm this conclusion in more detail. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|